Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells (original) (raw)

References

  1. Stetler-Stevenson, W.G., Aznavoorian, S. & Liotta, L.A., Tumor Cell interactions with the extra Cellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541–573 (1993).
    Article CAS Google Scholar
  2. Stetler-Stevenson, W.G., Liotta, L.A. & Kleiner, D.E., Cellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEBJ. 7, 1434–1441 (1993).
    Article CAS Google Scholar
  3. Albelda, S.M. Role of integrins and other Cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68, 4–17 (1993).
    CAS Google Scholar
  4. Wewer, U.M., Taraboletti, G., Sobel, M.E., Albrechtsen, R. & Liotta, L.A. Role of laminin receptors in tumor Cell migration. Cancer Res. 47, 5691–5698 (1987).
    CAS PubMed Google Scholar
  5. Lane, T.F. & Sage, E.H. The biology of SPARC, a protein that modulates Cell-matrix interactions. FASEB J. 8, 163–173 (1994).
    Article CAS Google Scholar
  6. Sage, E.H. & Bornstein, P., Cellular proteins that modulate Cell-matrix interactions. J. Biol. Chem. 266, 14831–14834 (1991).
    CAS PubMed Google Scholar
  7. Tremble, P.M., Lane, T.F., Sage, E.H. & Werb, Z. SPARC, a secreted protein associated with morphogenesis and tissue remodelling, induces expression of metalloproteinases in fibroblasts through a novel extraCellular matrix-dependent pathway. J. Cell Biol. 121, 1433–1444 (1993).
    Article CAS Google Scholar
  8. Porter, P.L., Sage, E.H., Lane, T.F., Funk, S.H. & Gown, A.M. Distribution of SPARC in normal and neoplastic tissue. J. Histochem. Cytochem. 43, 791–800 (1995).
    Article CAS Google Scholar
  9. Podhajcer, O.L. et al. Comparative expression of the SPARC and stromelysin-3 genes in mammary tumors. Breast 5, 13–20 (1996).
    Article Google Scholar
  10. Bellahcene, A. & Castronovo, V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am. J. Pathol. 146, 95–100 (1995).
    CAS PubMed PubMed Central Google Scholar
  11. Porte, H. et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int. J. Cancer 64, 70–75 (1995).
    Article CAS Google Scholar
  12. Ledda, F. et al. The expression of the secreted protein acidic and rich in cysteine, SPARC, is associated with the neoplastic progression of human melanoma. J. Invest. Dermatol. (in the press).
  13. Podhajcer, O.L. et al. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J. Invest. Dermatol. 104, 340–144 (1995).
    Article CAS Google Scholar
  14. Terranova, V.P., Williams, J.E., Liotta, L.E. & Martin, G.R. Modulation of the metastatic activity of melanoma Cells by laminin and fibronectin. Science 226, 982–985 (1984).
    Article CAS Google Scholar
  15. Kanemoto, T. et al. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc. Natl. Acad. Sci. USA 87, 2279–2283 (1990).
    Article CAS Google Scholar
  16. Seftor, R.E.B. et al. Role of the αvβ3 integrin in human melanoma Cell invasion. Proc. Natl. Acad. Sci. USA 89, 1557–1561 (1992).
    Article CAS Google Scholar
  17. Seftor, R.E.B., Seftor, E., Stetler-Stevenson, W.G. & Hendrix, M.J.C. The 72 kDa type IV collagenase is modulated via differential expression of αvβ3 and α5β1 integrins during human melanoma invasion. Cancer Res. 53, 3411–3415 (1993).
    CAS Google Scholar
  18. Sage, E.H., Vemon, R.B., Funk, S.E., Everitt, E.A. & Angello, J. SPARC, a secreted protein associated with Cellular proliferation, inhibits Cell spreading in vitro and exhibits Ca2+-dependent binding to the extraCellular matrix. J. Cell Biol. 109, 341–356 (1989).
    Article CAS Google Scholar
  19. Lane, T.F., Iruela-Arispe, M. & Sage, E.H. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1 and plasminogen activator inhibitor-1. J. Biol. Chem. 267, 16736–16745 (1992).
    CAS PubMed Google Scholar
  20. Kamihagi, K., Katayama, M., Ouchi, R. & Kato, I. Osteonectin/SPARC regulates extraCellular secretion rates of fibronectin and laminin extra Cellular matrix proteins. Biochem. Biophys. Res. Common. 200, 423–428 (1994).
    Article CAS Google Scholar
  21. Maurer, P. et al. High-affinity and low-affinity calcium binding and stability of the multidomain extraCellular 30-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur. J. Biochem. 205, 233–240 (1992).
    Article CAS Google Scholar
  22. Lane, T.F. & Sage, E.H. Functional mapping of SPARC: Peptides from two distinct sites modulate Cell adhesion. J. Cell Biol. 111, 3065–3076 (1990).
    Article CAS Google Scholar
  23. Pottgiesser, J. et al. Changes in calcium and collagen II binding caused by mutations in the EF hand and other domains of extraCellular matrix protein BM-40 (SPARC, osteonectin). J. Mol. Biol. 238, 563–574 (1994).
    Article CAS Google Scholar
  24. Funk, S.E., Sage, E.H. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial Cells and fibroblasts. J. Cell Physiol. 154, 53–63 (1993).
    Article CAS Google Scholar
  25. Lane, T.F., Iruela-Arispe, M.L., Johnson, R.S. & Sage, E.H. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J. Cell Biol. 125, 929–943 (1994).
    Article CAS Google Scholar
  26. Kochevar, G.J., Stanek, J.A. & Rucker, E.B. Truncated fibronectin. An autologous growth-promoting substance secreted by renal carcinoma Cells. Cancer 69, 2311–2315 (1992).
    Article CAS Google Scholar
  27. Lambert Vidmar, S., Lottspeich, F., Emod, Y., Planchenault, T. & Kleil-Dlouha, V. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur. J Biochem. 201, 71–77 (1991).
    Article CAS Google Scholar
  28. Mok, S.C., Chan, W.Y., Wong, K.K., Muto, M.G. & Berkowitz, R.S. SPARC, an extraCellular matrix protein with tumor-suppressing activity in human ovarian epithelial Cells. Oncogene 12, 1895–1901 (1996).
    CAS PubMed Google Scholar
  29. Funk, S.E. & Sage, E.H., Ca2+-binding glycoprotein SPARC modulates Cell cycle progression in bovine aortic endothelial Cells. Proc. Natl Acad. Sci. USA 88, 2648–2652 (1991).
    Article CAS Google Scholar
  30. Everitt, E.A. & Sage, E.H. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma Cells. Exp. Cell Res. 199, 134–146 (1992).
    Article CAS Google Scholar
  31. Oppenheim, J.J., Zachariae, C.O.C., Mukaida, N. & Matsushima, K. Properties of the novel proinflammatory supergene intercrineo cytokine family. Annu. Rev. Immunol. 9, 617–648 (1991).
    Article CAS Google Scholar
  32. Gilat, D., Cahalon, L., Harshkovitz, R. & Lider, O. Interplay of T Cells and cytokines in the context of enzymatically modified extraCellular matrix. Immunol. Today, 17, 16–20 (1996).
    Article CAS Google Scholar
  33. Mercola, D. & Cohen, J.S. Antisense approaches to cancer gene therapy. Cancer Gene Ther. 2, 47–59 (1995).
    CAS PubMed Google Scholar
  34. Trojan, J. et al. Treatment and prevention of rat glioblastoma by immunogenic C6 Cells expressing antisense insulin-like growth factor I RNA. Science 259, 94–97 (1993).
    Article CAS Google Scholar
  35. Laird, A.D., Brown, P.I. & Fausto, N. Inhibition of tumor growth in liver epithelial Cells transfected with a transforming growth factor α antisense gene. Cancer Res. 54, 4224–232 (1994).
    CAS PubMed Google Scholar
  36. Aoki, K., Yoshida, T., Sugimura, T. & Terada, M. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res. 55, 3810–3816 (1995).
    CAS PubMed Google Scholar
  37. Harlow, E. & Lane, D., Immunizationax. in: Antibodies: A Laboratory Manual. Ch. 5, 53–138 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1988).
    Google Scholar
  38. Rao, J.S. et al. Elevated levels of M, 92,000 type IV collagenase in human brain tumors. Cancer Res. 53, 2208–2211 (1993).
    CAS PubMed Google Scholar
  39. Yabkowitz, R., Mansfield, P.J., Dixit, V.M. & Suchard, S.J. Motility of human carcinoma Cells in response to thrombospondin: Relationship to metastatic potential and thrombospondin structural domains. Cancer Res. 53, 378–387 (1993).
    CAS PubMed Google Scholar
  40. Collier, I.E. et al. H-ras oncogene-transformed human bronchial epithelial Cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263, 6579–6587 (1988).
    CAS PubMed Google Scholar

Download references